NOVAVAX INC Purchase Agreements
13 Contracts & Agreements
- Amendment No. 4 to Advanced Purchase Agreement, dated as of July 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)
- Amendment No. 3 to Advanced Purchase Agreement, dated as of April 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)
- Amendment No. 2 to Advanced Purchase Agreement, dated as of April 6, 2022, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)
- Amendment No. 4 to Advanced Purchase Agreement, effective as of June 30, 2023, between the Company and His Majesty the King in Right of Canada, as represented by the Minister of... (Filed With SEC on August 8, 2023)
- Amendment No. 3 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)
- Amendment No. 2 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)
- Amendment No. 1 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)
- Amendment to Advance Purchase Agreement between the Company, and the Commonwealth of Australia as represented by the Department of Health, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)
- Advance Purchase Agreement, dated August 16, 2021, between Novavax, Inc., Novavax CZ and the European Commission (Filed With SEC on November 5, 2021)
- Advance Purchase Agreement, dated May 5, 2021, between Novavax, Inc. and the Gavi Alliance (Filed With SEC on August 5, 2021)
- Advance Purchase Agreement, effective as of January 19, 2021, between Novavax, Inc. and Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Works... (Filed With SEC on March 1, 2021)
- Advance Purchase Agreement, effective as of December 31, 2020, between Novavax, Inc. and the Commonwealth of Australia as represented by the Department of Health (Filed With SEC on March 1, 2021)
- Asset Purchase Agreement between Novavax, Inc. and Paragon Bioservices, Inc. dated June 26, 2019 (Filed With SEC on August 7, 2019)
